CCN6 as a profibrotic mediator that stimulates the proliferation of lung fibroblasts via the integrin β1/focal adhesion kinase pathway

Journal of Medical Investigation

Volumn 58, Issue 3-4, 2011, Pages 188-196

  Batmunkh, Rentsenkhand ^a   Nishioka, Yasuhiko ^a   Aono, Yoshinori ^a   Azuma, Momoyo ^a   Kinoshita, Katsuhiro ^a   Kishi, Jun ^a   Makino, Hideki ^a   Kishi, Masami ^a   Takezaki, Akio ^a   Sone, Saburo ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

CCN; Fibroblasts; Focal adhesion kinas; Integrin; Proliferation

Indexed keywords

BETA1 INTEGRIN; BLEOMYCIN; CCN PROTEIN; CCN6 PROTEIN; FIBRONECTIN; FOCAL ADHESION KINASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL GROWTH; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; EXTRACELLULAR MATRIX; FIBROGENESIS; LUNG FIBROBLAST; MOUSE; NONHUMAN; PROTEIN BINDING; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; SIGNAL TRANSDUCTION; TISSUE DISTRIBUTION;

MUS;

EID: 80052809211     PISSN: 13431420     EISSN: None     Source Type: Journal    
DOI: 10.2152/jmi.58.188     Document Type: Article

References (39)

1. Gross TJ, Hunninghake GW: Idiopathic pulmonary fibrosis. N Engl J Med 16; 345(7): 517-25,2001
2. Selman M, King TE, Pardo A: Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann Intern Med 16; 134(2): 136-51, 2001
3. American Thoracic Society: Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am J Respir Crit Care Med; 161(2 Pt 1): 646-64, 2000
4. Collard HR, King TE, Jr: Demystifying idi- opathic interstitial pneumonia. Arch Intern Med 13; 163(1): 17-29, 2003
5. Brigstock DR, Goldschmeding R, Katsube KI, Lam SC, Lau LF, Lyons K, Naus C, Perbal B, Riser B, Takigawa M, Yeger H: Proposal for a unified CCN nomenclature. Mol Pathol; 56(2): 127-8, 2003
6. Chen CC, Lau LF: Functions and mechanisms of action of CCN matricellular proteins. Int J Biochem Cell Biol; 41(4): 771-83, 2009
7. Holbourn KP, Perbal B, Ravi Acharya K: Pro- teins on the catwalk: modelling the structural domains of the CCN family of proteins. J Cell Commun Signal; 3(1): 25-41, 2009
8. Leask A, Abraham DJ: All in the CCN family: essential matricellular signaling modulators emerge from the bunker. J Cell Sci 1; 119(Pt 23): 4803-10, 2006
9. Perbal B: CCN proteins: multifunctional sig- nalling regulators. Lancet 3; 363(9402): 62-4, 2004
10. Perbal BV, Takigawa M. CCN proteins: a new family of cell growth and differentiation regulators: London; Hackensack, NJ: Imperial College Press; 2005.
11. Brigstock DR: Strategies for blocking the fibrogenic actions of connective tissue growth factor (CCN2): From pharmacological inhibition in vitro to targeted siRNA therapy in vivo. J Cell Commun Signal; 3(1): 5-18, 2009
12. Pan LH, Yamauchi K, Uzuki M, Nakanishi T, Takigawa M, Inoue H, Sawai T: Type II alveo- lar epithelial cells and interstitial fibroblasts ex- press connective tissue growth factor in IPF. Eur Respir J; 17(6): 1220-7, 2001
13. Lasky JA, Ortiz LA, Tonthat B, Hoyle GW, Corti M, Athas G, Lungarella G, Brody A, Friedman M: Connective tissue growth factor mRNA expression is upregulated in bleomycin- induced lung fibrosis. Am J Physiol; 275(2 Pt 1): L365-71, 1998
14. Bonniaud P, Martin G, Margetts PJ, Ask K, Robertson J, Gauldie J, Kolb M: Connective tissue growth factor is crucial to inducing a profibrotic environment in"fibrosis-resistant" BALB/c mouse lungs. Am J Respir Cell Mol Biol; 31(5): 510-6, 2004
15. Konigshoff M, Kramer M, Balsara N, Wilhelm J, Amarie OV, Jahn A, Rose F, Fink L, Seeger W, Schaefer L, Gunther A, Eickelberg O: WNT1-inducible signaling protein-1 mediates pulmonary fibrosis in mice and is upregulated in humans with idiopathic pulmonary fibrosis. J Clin Invest; 119(4): 772-87, 2009
16. Huang W, Gonzalez ME, Toy KA, Banerjee M, Kleer CG: Blockade of CCN6 (WISP3) activates growth factor-independent survival and resistance to anoikis in human mammary epithelial cells. Cancer Res 15; 70(8): 3340-50, 2010
17. Hurvitz JR, Suwairi WM, Van Hul W, El-Shanti H, Superti-Furga A, Roudier J, Holderbaum D, Pauli RM, Herd JK, Van Hul EV, Rezai-Delui H, Legius E, Le Merrer M, Al-Alami J, Bahabri SA, Warman ML: Mutations in the CCN gene family member WISP3 cause progressive pseu- dorheumatoid dysplasia. Nat Genet; 23(1): 94-8,1999
18. Kireeva ML, Latinkic BV, Kolesnikova TV, Chen CC, Yang GP, Abler AS, Lau LF: Cyr61 and Fisp12 are both ECM-associated signaling molecules: activities, metabolism, and localiza- tion during development. Exp Cell Res 25; 233(1): 63-77, 1997
19. Aono Y, Nishioka Y, Inayama M, Ugai M, Kishi J, Uehara H, Izumi K, Sone S: Imatinib as a novel antifibrotic agent in bleomycin-induced pulmonary fibrosis in mice. Am J Respir Crit Care Med 1; 171(11): 1279-85, 2005
20. Azuma M, Nishioka Y, Aono Y, Inayama M, Makino H, Kishi J, Shono M, Kinoshita K, Uehara H, Ogushi F, Izumi K, Sone S: Role of alpha1-acid glycoprotein in therapeutic antifi- brotic effects of imatinib with macrolides in mice. Am J Respir Crit Care Med 15; 176(12): 1243-50, 2007
21. Harrison JH, Jr., Lazo JS: High dose continu- ous infusion of bleomycin in mice: a new model for drug-induced pulmonary fibrosis. J Pharma- col Exp Ther; 243(3): 1185-94, 1987
22. Inayama M, Nishioka Y, Azuma M, Muto S, Aono Y, Makino H, Tani K, Uehara H, Izumi K, Itai A, Sone S: A novel IkappaB kinase-beta inhibitor ameliorates bleomycin-induced pul- monary fibrosis in mice. Am J Respir Crit Care Med 1; 173(9): 1016-22, 2006
23. Kishuku M, Nishioka Y, Abe S, Kishi J, Ogino H, Aono Y, Azuma M, Kinoshita K, Batmunkh R, Makino H, Ranjan P, Minakuchi K, Sone S: Expression of soluble vascular endothelial growth factor receptor-1 in human monocyte- derived mature dendritic cells contributes to their antiangiogenic property. J Immunol 15; 183(12): 8176-85, 2009
24. Nishioka Y, Nishimura N, Suzuki Y, Sone S: Human monocyte-derived and CD83(+) blood dendritic cells enhance NK cell-mediated cyto- toxicity. Eur J Immunol; 31(9): 2633-41, 2001
25. Nishioka Y, Manabe K, Kishi J, Wang W, Inayama M, Azuma M, Sone S: CXCL9 and 11 in patients with pulmonary sarcoidosis: a role of alveolar macrophages. Clin Exp Immunol; 149(2): 317-26, 2007
26. Thannickal VJ, Toews GB, White ES, Lynch JP, 3rd, Martinez FJ: Mechanisms of pulmonary fibrosis. Annu Rev Med; 55: 395-417, 2004
27. Davis L, Chen Y, Sen M: WISP-3 functions as a ligand and promotes superoxide dismutase activity. Biochem Biophys Res Commun 31; 342(1): 259-65, 2006
28. Sen M, Cheng YH, Goldring MB, Lotz MK, Carson DA: WISP3-dependent regulation of type II collagen and aggrecan production in chondrocytes. Arthritis Rheum; 50(2): 488-97, 2004
29. Xia H, Diebold D, Nho R, Perlman D, Kleidon J, Kahm J, Avdulov S, Peterson M, Nerva J, Bitterman P, Henke C: Pathological integrin signaling enhances proliferation of primary lung fibroblasts from patients with idiopathic pulmo-nary fibrosis. J Exp Med 7; 205(7): 1659-72, 2008
30. Grzeszkiewicz TM, Kirschling DJ, Chen N, Lau LF: CYR61 stimulates human skin fibroblast migration through Integrin alpha vbeta 5 and enhances mitogenesis through integrin alpha vbeta 3, independent of its carboxyl-terminal domain. J Biol Chem 15; 276(24): 21943-50, 2001
31. Schutze N, Schenk R, Fiedler J, Mattes T, Jakob F, Brenner RE: CYR61/CCN1 and WISP3/CCN6 are chemoattractive ligands for human multipotent mesenchymal stroma cells. BMC Cell Biol; 8: 45, 2007
32. Frisch SM, Vuori K, Ruoslahti E, Chan-Hui PY: Control of adhesion-dependent cell sur- vival by focal adhesion kinase. J Cell Biol; 134 (3): 793-9, 1996
33. Kumar CC: Signaling by integrin receptors. Oncogene 17; 17(11 Reviews): 1365-73, 1998
34. Parsons JT: Focal adhesion kinase: the first ten years. J Cell Sci 15; 116(Pt 8): 1409-16, 2003
35. Thannickal VJ, Lee DY, White ES, Cui Z, Larios JM, Chacon R, Horowitz JC, Day RM, Thomas PE: Myofibroblast differentiation by transforming growth factor-beta1 is dependent on cell ad- hesion and integrin signaling via focal adhesion kinase. J Biol Chem 4; 278(14): 12384-9, 2003
36. Grotendorst GR, Rahmanie H, Duncan MR: Combinatorial signaling pathways determine fibroblast proliferation and myofibroblast differentiation. FASEB J; 18(3): 469-79, 2004
37. Kireeva ML, Mo FE, Yang GP, Lau LF: Cyr61, a product of a growth factor-inducible immediate-early gene, promotes cell proliferation, migration, and adhesion. Mol Cell Biol; 16(4): 1326-34, 1996
38. Phan SH, Varani J, Smith D: Rat lung fibroblast collagen metabolism in bleomycin-induced pulmonary fibrosis. J Clin Invest; 76(1): 241-7,1985
39. Kleer CG, Zhang Y, Merajver SD: CCN6 (WISP3) as a new regulator of the epithelial phenotype in breast cancer. Cells Tissues Organs; 185(1-3): 95-9, 2007